Please provide your email address to receive an email when new articles are posted on . Recombinant human bone morphogenetic proteins have come a long way since their introduction into the clinical ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. MONTREAL — Results of a randomized, prospective study of ...
To determine if use of an osteogenic agent (rhBMP-2) at the time of surgical treatment for tibial pseudarthosis in NF1 patients will result in improved bone healing when compared to NF1 patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results